The Safety and Efficacy of Neramexane in Patients With Moderate to Severe Alzheimer's Disease

Behavioral Medical Research of Saten Island, PC, Staten Island

Nathan S. Kline Institute for Psychiatric Research, Orangeburg

Upstate Clinical Research, Albany

Monroe Community Hospital, Rochester

Piedmont Medical Research, Winston-Salem

Medical University of South Carolina, Charleston

Berma Research Group, Hialeah

Baumel-Eisner Neuromedical Institute, Fort Lauderdale

Neurology Clinical Research, Inc., Plantation

Palm Beach Neurology, West Palm Beach

Palm Beach Neurological Center, Palm Beach Gardens

University of South Florida, Tampa

Lexington Clinic, Lexington

Neurology and Neuroscience Center of Ohio, Toledo

Indiana Universisty Medical Center, Indianapolis

Mood and Memory Clinic of Michigan, Farmington Hills

St. Louis University, St Louis

J. Gary Booker, MD, Shreveport

North Texas Neurology Research, Wichita

University of Colorado Health Sciences Center, Denver

Pioneer Pharmaceutical Research, Midvale

21st Century Neurology, Phoenix

Pivotal Research Centers, Peoria

Pharmacology Research Institute, Northridge

Pacific Research Network, San Diego

Affiliated Research Institute, San Diego

UCI Medical Center, Orange

Margolin Brain Institute, Fresno

Summit Research Network, Portland

Ohio State University, Columbus

Yale University School of Medicine, New Haven

Alzheimer's Research Corporation, Lakehurst

Joel Ross, MD, Long Branch

Ubhc/Umdnj, Piscataway